Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia areata affects life quality differently based on its severity.

Salmon patches on the neck may relate to the severity and recurrence of alopecia areata.

Low levels of zinc and ferritin may be linked to the severity of alopecia areata in Iraqi patients.

Human Beta Defensin 1 levels do not predict the risk or severity of Alopecia Areata.

Androgenetic alopecia linked to COVID-19 severity; drugs reducing androgen receptor activation may help.

A scale was made to measure hair loss severity in African American women.

Tailored treatments for alopecia areata are recommended based on severity and patient needs.

Alopecia areata patients may have hearing loss linked to the condition's severity and duration.

Hair loss link to COVID-19 severity likely due to other factors.

Certain N-glycans may help assess hair loss severity in men with female-pattern hair loss.

β1 integrin may indicate and influence the severity of hair loss in androgenetic alopecia.

There's a significant link between the severity of Seborrheic Dermatitis and the pattern of hair loss in people with a family history of hair loss.

PON1 levels might indicate hair loss severity, but other health factors can affect this.

Pediatric hair loss requires personalized treatment based on cause and severity, with specialist support.

The Polish Society of Dermatology recommends treatments for alopecia areata that vary by severity, including topical and systemic medications, with long-term maintenance important for management.

A new classification and scoring system is needed for alopecia areata to better assess severity.

NF-κB levels can help diagnose and assess the severity of androgenetic alopecia.

Trichoscopy helps diagnose and assess the severity of Frontal Fibrosing Alopecia.

Alopecia areata impacts mental well-being more due to perceptions and stigma than disease severity.

No significant link between male pattern baldness and COVID-19 severity was found.

Alopecia areata is significantly linked to thyroid issues and may worsen with diabetes severity.

Higher miR-34a levels and the A variant of the MIR-34A gene are linked to increased risk and severity of alopecia areata.

Higher Galectin-3 levels are linked to insulin resistance and may predict androgenetic alopecia severity.

Higher levels of IL-1R1 and hsa-miR-19b-3p may help diagnose and predict alopecia areata severity.

People with Alopecia areata often have lower Vitamin D levels, which might affect the severity of their condition.

Alopecia areata treatment should be personalized, using topical or systemic therapies based on severity, with promising options like JAK inhibitors needing more research.

The document suggests a personalized treatment plan for alopecia areata based on the patient's age and hair loss severity, using a range of therapies ranked by effectiveness and safety.

Alopecia areata is an unpredictable autoimmune hair loss condition, treated based on severity, with half of patients regrowing hair within a year without treatment.

A woman's hair grew back after stopping acitretin for psoriasis and getting steroid treatment, and low vitamin D might be linked to alopecia severity.

Most patients with autoimmune blistering diseases experienced some hair loss, which may be underreported and linked to disease severity.